Initial oral infection of pigs with either highly virulent (L-60) or moderately virulent (DR-2) African swine fever virus (ASFV), followed in 3 days with exposure to foot-and-mouth disease virus (FMDV) (IDCs) 15 known to be essential for presentation of an-31
African swine fever (ASF) was first described in 1921 inoculated with RPV, and pigs vaccinated for 122 days as an acute fatal viral disease of pigs causing necrosis were inoculated with FMDV or AHCV. All pigs were and hemorrhage in the spleen and lymph nodes and challenged 3-8 days later with the virulent L-60 strain other organs. 37 In domestic pigs, virulent ASF was leof ASFV. About half of each group had died by 2 weeks thal and self-limiting. Only after ASF became estabafter inoculation, and these pigs had pneumonic lesions lished in Portugal and following a vaccination camattributed to ASF. High fevers were reported between paign in 1963 with an attenuated live vaccine 30 did 2 and 6 days postinoculation (DPI) with both rindersubacute and chronic ASF occur frequently. With the pest and foot-and-mouth disease (FMD) . No lesions modification of the disease in the Iberian peninsula, or deaths were reported due to these viruses, but it the finding of field isolates of low and moderate virprobably can be assumed that FMDV caused typical ulence stimulated studies to determine the effects of vesicular disease or it would have been mentioned. ASF on the immune system. Recovered pigs were found Another study (Gamett W, Ferris DH, unpublished) to have high levels of circulating antibody concurrently was undertaken following laboratory reports from Spain with high levels of ASF virus (ASFV), 7,9 which sugthat HCV and ASFV were present simultaneously in gested that the immune system was not impaired in field samples. Pigs were inoculated with virulent HCV pigs infected with less virulent isolates. To test this and moderately virulent (DR-2) ASFV simultaneoushypothesis, pigs were vaccinated with an attenuated ly, and infection with both was detected for up to 2 ASFV and 2 months later were challenged with footweeks by direct immunofluorescence of tissues and and-mouth disease virus (FMDV). 6 A normal antibody antibody was detected to both by serologic tests. response was reported 21 days later.
None of these studies addressed the dicotomy of an Following a report from Portugal that pigs vacciapparent lack of a humoral immune response to virnated with the attenuated ASF vaccine were suffering ulent ASFV, although there is an essentially normal from postvaccinal "stress" and chronic pneumonia, 30 immune response in pigs infected with moderately virthe possible role of stress was investigated in vacciulent ASFV, albeit not neutralizing. 19 An ASF pathonated pigs. 8 The "stressors" applied were virulent ringenesis study 35 showed that early viral replication in derpest virus (RPV), FMDV, and attenuated hog cholthe tonsil and mandibular lymph node occurred in era virus (AHCV). Pigs vaccinated for 66 days were reticuloendothelial cells of the paracortex. The authors suggested that these cells might be antigen-presenting cells, and their infection may modulate the immune tigen in a primary immune response. 2,24 Infection of IDCs by ASFV and marked suppression of S-100 protein expression, a specific IDC marker, has been detected at 3 DPI, with S-100 suppression continuing to at least 14 DPI. 14 In this article, we describe an experiment initially designed to assess the ability of dendritic cells to present a novel antigen during the acute phase of either virulent or moderately virulent ASFV infection. Virulent FMDV was chosen as the challenge antigen because of its rapid replication, obvious vesicular formation in the pig, and ability to produce a measurable primary immune response within 6 DPI, 38 the window of time between 3 DPI and death in acute ASF. The serendipitous discovery of interference with FMDV infection in ASFV-infected pigs is discussed. oculated with DR-2 ASFV at -3 DPI, and 2 normal pigs were added at 0 DPI; all pigs were inoculated with FMDV at 0 DPI as in group DR-2b. Blood samples were taken at 0 DPI for ASFV isolation and at 4, 9, 18, and 24 DPI for FMDV isolation. Sera were collected at 4, 9, 18, and 24 DPI. Final necropsies were done at 24 DPI.
Animals
Conventional Yorkshire crossbred pigs from a closed herd were used at weights of 15-25 kg, 20-30 kg, and 40-60 kg. All pigs were housed in animal rooms in the P-3 level biocontainment Foreign Animal Disease Diagnostic Laboratory. Pigs in severe distress and surviving pigs at the end of the experiments were euthanized with an overdose of sodium pentothal.
Viruses and inoculations
A moderately virulent isolate of ASFV from the Dominican Republic isolated in 1979 (DR-2) was used for 3 experiments. For comparison, a highly virulent isolate from Portugal, designated Lisbon-60 (L-60), was used for 2 experiments. Stock virus was prepared from an acutely viremic pig by homogenizing defibrinated blood and spleen (80/20) and storing the samples at -70 C. Inoculum was prepared from freshly thawed stock virus diluted 10-fold in Eagle's minimal essential medium (MEM) and centrifuged at 800 x g for 15 min. Supernatant fluid containing approximately 10 3 hemadsorption 50 (HAd 50 ) units was inoculated by the oralnasal route. Virulent cell-adapted DR-2 ASFV was cultivated in Vero cells and frozen at -70 C.
Foot-and-mouth disease virus type O1 Bruge was harvested from infected bovine tongue tissue and passaged twice in bovine kidney primary cells and once in third-passage lamb kidney cells. Stock virus prepared from the cell lysate was stored at -70 C. Pig inoculation with FMDV was by the IDL route with approximately 10 3 TCID 50 /0.1 ml in a single site on the distal part of the tongue.
Sample collection
Blood samples were collected on the day of inoculation with ASFV (designated as -3 DPI) and 3 days later when inoculated with FMDV (0 DPI) and at 3-4-day intervals until the end of clinical ASF (7-9 DPI). Following clinical recovery, blood samples were collected from remaining pigs approximately weekly. Heparinized blood samples were collected for ASFV or FMDV isolation and stored at -70 C. Serum was separated and stored at -20 C.
Virus isolation
For FMDV isolation, heparinized blood was thawed and diluted 1:10 in MEM; 1 ml was inoculated into 2 25-cm 2 flasks containing primary lamb kidney cells 21 and 5 ml of MEM with 5% heat-inactivated fetal bovine serum (FBS), 300 µg gentamycin, and 2.5 µg of amphotericin-B (AB) per milliliter. Cell cultures were observed daily for 4 days, and all flasks without cytopathic effect (CPE) were subpassaged twice before being considered negative. Cell culture flasks in which CPE was evident were confirmed as positive for FMDV type O1 by the complement fixation test. 49 Routine controls were run simultaneously.
Isolation of ASFV was done on primary swine buffy coat (BC) cultures. Swine BC, prepared by a standard method, 18 was dispensed at 0.3 ml/well in 8-chamber slides a (approximately 10 5 cells) and incubated at 37 C overnight before use. For detection of viral infectivity, 10-fold dilutions of blood in MEM were inoculated into 2 wells each (0.1 ml/ well). Cultures were examined for hemadsorption daily for 7 days and were reported as the reciprocal of the log of the end point dilution having at least 1 positive well.
Serology
VN titers for FMDV were determined by the microtiter method. 47 All dilutions of virus, cells, and sera were made in MEM with FBS and AB. The optimal dilution of test virus, 100 (range, 40-400) TCID 50 /0.1 ml, was determined on the Mengeling-Vaughn porcine kidney cell line. Optimally diluted FMDV (isolate O1 Lombardi) was added to an equal volume of 2-fold-diluted heat-inactivated test serum prepared in triplicate. After 1 hr, cells were added and incubated for 3 days at 37 C. Final VN titers were calculated. 1l Positive and negative control sera and back titrations were routinely done.
Serologic titrations for antibody to ASFV were determined by a modification of the indirect immunoperoxidase plaque staining method. 41 The procedure was modified by the substitution of the avidin-biotin complex alkaline phosphatase (ABC-AP) enzyme staining system b for the peroxidase system. Chamber slides a with ASFV-infected plaques on Vero cells were fixed with paraformaldehyde-lysine-periodate fixative. 31 Before use, slides were rinsed in phosphate-buffered saline (PBS) briefly and in 2% glycine for 30 min at 20 C. Blocking normal rabbit serum (2%) in PBS with 0.001% Tween 20 c (PBSTw) was applied dropwise, incubated 30 min at 37 C in a humidified incubator, and shaken off before addition of lo-fold dilutions of test sera (1:20-1:20,000) and incubation at 4 C overnight. Slides were rinsed 3 times for 5 min each in PBSTw between all remaining steps. Biotinylated rabbit anti-swine serum b (1:300 in PBSTw) was incubated 1 hr at 37 C, followed by ABC-AP for 1 hr at 37 C and red substrate indicator b for 45 min at 20 C. Slides were coverslipped with Permount d and examined with a light microscope. Titers are reported as the reciprocal of the log of the last dilution with focal red staining in the cell cytoplasm. Positive and negative control sera were processed in each batch.
Results
The results of the control group of FMDV-infected pigs are summarized in Table 1 . This set of pigs was inoculated with only FMDV for comparing the day of onset of fever, viremia, and VN antibody detection. The onset of fever was at 2-4 DPI. Virus was isolated from 9 of 10 pigs at 3 DPI. Antibody titers were detectable at 7 DPI in all pigs. Clinical disease was severe and consistent with this isolate. At 2 DPI, all pigs had multiple 0.5-1-cm blanched and friable vesicles on the tongue, often with extensive erosions. These lesions not only involved the site of inoculation but extended at least 1-2 cm around it. At 3 DPI, all but 2 pigs had extensive unruptured or freshly ruptured vesicles on 3 or 4 feet, and a few also had large snout vesicles. Pig 86 and 83 each had a tongue lesion at 3 DPI and later developed vesicles on all 4 feet by 5 and 7 DPI, respectively. Vesicles on the feet usually ruptured at the posterior margin of the foot pad within 24 hours, developing into deep erosions and eventually undermining and separating the wall of the hoof at the coronary band. Some hooves were lost by 14 DPI (Fig. 1) .
Results of the L-60a group are summarized in Table  2 . All pigs were inoculated with ASFV. Eight pigs had the onset of a fever of > 41.5 C by 1 day after FMDV inoculation. Of these 8 pigs, none developed even a primary vesicle on the tongue, nor was FMDV isolated or antibody to FMDV detected up to 6 DPI. One pig at 7 DPI had a low VN titer to FMDV. Two remaining pigs (202, 203) did not develop fevers until 2 and 5 DPI, respectively. Of these, pig 202 developed a tongue vesicle at 2 DPI and a snout vesicle at 3 DPI and became lame. Pig 212 became lame at 4 DPI, but vesiculation was not clinically apparent. Neither of these pigs became viremic with ASFV until after 3 DPI, at which time they were already viremic with FMDV. These 2 pigs and 1 other (nos. 202, 212, 199) survived to 7 DPI and developed antibody to FMDV. All pigs had gross lesions of acute ASF, including a spleen that was enlarged 2-3 times, congested, and friable and diffusely hemorrhagic mandibular, gastrohepatic, renal, and iliac lymph nodes. Kidneys were congested, and there were ecchymotic hemorrhages in the renal pelvis. Lungs were congested and edematous.
Results of group L-60b are recorded in Table 3 . These results are similar to those of group L-60a. Most pigs were free of generalized FMD lesions. Five of 12 ASFVinfected pigs developed small 1-2-mm focal areas of blanched necrotic epithelium at the injection site of FMDV but no other FMD lesions. The 2 normal pigs introduced at 0 DPI and inoculated with FMDV had at 3-4 DPI onset of fever and severe tongue and foot vesiculation. Both of these pigs and 1 ASFV-inoculated pig that had a focal tongue lesion developed detectable antibody to FMDV by 5 DPI. All 14 pigs had gross lesions of ASF as described for the L-60a group.
Results of group DR-2a are summarized in Table 4 . These results are essentially identical to the results of Table 5 . These pigs 208 had no apparent vesicles but was noted to be lame were slightly larger than pigs in the previous groups, at 3 DPI. This pig had detectable antibody to FMDV and all pigs survived to at least 7 DPI. All pigs were at 5 DPI. Three other pigs had low titers to FMDV at viremic with ASFV at 0 DPI when inoculated with 7 DPI. Gross lesions of ASF were similar to those in FMDV. Again, all but 1 pig developed a fever of > 40.5 group L-60a.
C by the first day after inoculation with FMDV. Only 1 pig developed a small 1-2-mm circumscribed area of blanched epithelium on the tongue at 2 DPI. None of these pigs became viremic with FMDV or seroconverted by 7 DPI. By 10 DPI, most pigs that were to survive to the end of the experiment appeared clinically normal despite intermittent days of fever. Two of these pigs remained seronegative to FMDV and free of FMD lesions up to 24 DPI. Two other surviving pigs developed snout and/or foot vesicles at 10 and 14 DPI and high levels of antibody to FMDV by 17 DPI. The 2 introduced FMDV-infected contacts developed severe vesicular lesions similar to those of the FMD group, became viremic with FMDV, and developed moderate antibody to FMDV by 7 DPI. Both of these pigs continued to have elevated temperatures and died with gross lesions of acute ASF. Half of the ASFVinoculated pigs had gross lesions similar to but less severe than those of the L-60 pigs. The others had no significant gross lesions except hyperplastic lymph nodes.
Results of group DR-2c are summarized in Table 6 . This was a group of large (40-60 kg) pigs, and results differed considerably from those of other groups. The onset of fever was variable between 1 and 3 DPI. One third of the pigs developed minimal or no lesions of FMD (Fig. 2 ) but slowly developed low to moderate antibody responses to FMDV. The rest of the pigs had moderate to severe vesicular disease and produced moderate antibody levels to FMDV. Only the 2 normal pigs added on day 0 (and inoculated with FMDV) and 1 experimental pig died with lesions of acute ASF. Another pig died from exsanguination due to a gastric ulcer at 16 DPI. None of the other pigs had significant gross lesions at 24 DPI.
Discussion
These experiments were designed to test the possibility that early infection of antigen-presenting cells by ASFV could result in complete or partial failure of presentation of a second antigen. The basis for the work was a hypothesis developed from pathogenesis studies that highly virulent ASF infection incapacitated antigen-presenting ce11s. 32, 33, 35 Additional impetus for the ASF-FMD study was the finding in subsequent pathogenesis studies 14, 15 that cells that were initially infected were identified by immunostaining and electron microscopy to be interdigitating dendritic cells. These IDCs were found to be infected as early as 3 DPI, usually 1 day before fever and clinical signs of ASF. At 3 DPI, there was also a marked diffuse decrease in the expression of S-100 protein, a specific marker for IDCs. S-100 protein is a calciumbinding protein believed important for cytoskeletal function and cytoplasmic dendrite extension and contraction, 27, 43 and its expression probably relates to cell function. This suppression of S-100 expression in DR-2-infected pigs continued to at least 14 DPI. 14 The IDC is a highly specialized cell related to Langerhans cells (LCs) and other dendritic antigen-presenting cells, which are subpopulations of the mononuclear phagocytic system. 21, 26 Dendritic cells bind readily to T cells without prior antigenic priming and are believed to be essential for the presentation of a novel antigen in a primary immune response. 24, 36 We hypothesized that if IDCs were lytically infected with virulent ASFV, their antigen presentation function would be abrogated and little or no antibody would be produced to ASFV or other novel antigens during this acute ASF infection. In contrast, if only part of the IDC population were infected or all were infected but retained some functional capacity, some antigen would be presented and result in a near normal humoral immune response. This is believed to be the case in subacute ASF.
To test this hypothesis, pigs of different age groups were infected with. highly virulent or moderately virulent ASFV and challenged 3 days later with a novel antigen (FMDV) at a time when IDC function was believed to be initially suppressed. Little or no immune response to FMDV (or ASFV) was expected with virulent ASFV within 6-7 days after FMDV exposure. Some immune response to both FMDV and ASFV was expected in this time frame from pigs that developed subacute ASF and recovered clinically.
What was not anticipated was that ASFV-infected pigs would not become infected with FMDV. For that reason, groups L-60a and DR-2a did not have FMDVinfected contacts introduced at 3 DPI to insure infection. Nevertheless, 2 pigs in group L-60a and 1 in group DR-2a did become viremic with FMDV and served * Fever of >42.5 C. DPI = days postinoculation. † Lesions graded from none (-) to severe (+ + + + +). ‡ Lesions present (+) or absent (-). § FMD VN = FMD virus neutralization antibody titer; ASF AB = ASF virus antibody 2 x log 10 by modified IIPS method; FMDV = presence (+) or absence (-) of FMD virus after inoculation at 0 DPI; ASFV = ASF virus isolation log 10 HAd 50 after inoculation with highly virulent L-60 isolate at -3 DPI.
|| Focal tongue lesion only. ¶ Postmortem sample. # FMD contact animals (controls). as infected contact animals to continue exposure of the other pigs to FMDV. Despite this massive contact exposure to FMDV in each room, nearly all pigs that were viremic with ASFV at the time of exposure to FMDV in groups L-60a, L=60b, DR-2a, and DR-2b failed to develop clinical FMD and were not detected to be viremic with FMDV. Only 7 of 42 pigs seroconverted to FMDV by 7 DPI, most at a low level. The failure to infect 4 pigs with ASFV in groups L-60a, L=60b, and DR-2a can be attributed to the intentionally low dose of ASFV used to inoculate these pigs. In prior studies with more inoculum, many pigs with acute ASF infections died before 9 or 10 DPI (data not shown), a result that would have precluded collecting a 6-7-DPI serum sample in this study. Others reported a similar failure to consistently infect pigs with DR'79 ASFV isolate by the intranasal-oral route, even with larger inocula. 32 Similar studies 16, 42 also found that the infectious dose for 2 different highly virulent ASFV isolates were 10 3.5-103.9 and 10 5.4 HAd 50 , respectively, when given orally or by intranasal inoculation.
The results of groups L-60a, L=60b, and DR-2a should be considered together, as groups having acute ASFV infections. Even though DR-2 is considered a moderately virulent virus, virulence in ASF is dependent on the size and condition of the pig. 4, [44] [45] [46] In pigs ≥20−30 kg, mortality with a similar moderately virulent DR'79 ASFV was 10-20%. 32 In pigs <20 kg, mortality may reach 50% and pigs die in 7-10 days, having gross lesions similar to pigs dying following inoculation with the L-60 isolate (McVicar JW, DAG, personal observations). As expected, group DR-2b had a higher death loss than did group DR-2c. In the DR-2b group, all pigs survived DR-2 ASFV infection for at least 10 days, but by 25 days, 6 of 10 had died. In contrast, in the larger (40-60 kg) pigs in group DR-2c, only 2 of 14 died. The pattern of disease and rate of survival of group DR-2c is similar to that reported by others. 32, 35 In group DR-2b, pigs 99 and 100 were free of FMD lesions until 14 and 10 DPI, respectively. These pigs then developed severe FMD lesions on the feet, and by 17 DPI, they had high VN titers to FMDV. The onset of these FMD cases coincided with decreased fever and clinical recovery from ASF. This finding suggests that the mechanism of interference between ASF and FMD was apparently abrogated upon clinical recovery in these 2 pigs. In contrast, pigs 82 and 92 did not develop FMD lesions nor did they seroconvert to FMDV up to 24 DPI in spite of exposure to active cases of FMD beginning at 2 DPI and repeated at 10 DPI and 14 DPI. This is a remarkably long period of viral interference.
Nearly all studies of viral interference between 2 viruses belonging to different families have implicated 1 of the interferons (IFNs). Interferon-alpha is produced primarily by leukocytes, and interferon-beta is produced primarily by fibroblasts in response to viral infections. 17 These type I interferons are produced within hours of viral infection. The RNA-containing viruses are the best inducers of IFN, and DNA viruses are poor inducers, with the exception of pox viruses. 25 Evidence for IFN production in ASF is scant. Cultured swine spleen cells infected with ASFV have produced IFN-alpha, however at a low level, and none has been detected in the blood of ASFV-infected pigs. 13 Interferon-gamma is produced by large granular lymphocytes and sensitized T cells stimulated with specific antigen.
10 Production of IFN-gamma is much slower than that of type I IFNs, particularly in a primary immune response. 5 Interferon induction lasts for several days and then decays and cannot be reinduced for several more days. 25 Based on these findings, continuous interference with FMD infection for up to 24 days seems unlikely to involve the action of IFNs alone.
A more likely explanation may be that ASFV infects and depletes or renders inactive the target cell for FMDV. Such heterologous interference has been demonstrated between measles virus and canine distemper virus. Live measles virus vaccination protects puppies from canine distemper as early as 24 hours postvaccination. 20, 34 Measles virus infection was detected in 80-90% of canine lymphocytes in vitro, which produced little virus, and protected lymphocytes from superinfection with canine distemper virus. 20 Interference was believed to be at the intracellular level.
The target cell of FMDV may be the LC in the epidermis. In 1 study, 12 FMDV antigen was detected by immunofluorescence in infected guinea pig foot pad epidermis at 24 hours postinfection but not in keratinocytes until 48 hours. Infection of LCs was confirmed in vitro by isolation of LCs from trypsinized skin. There is good evidence that LCs in the skin migrate via the lymph to the lymph node and quickly mature into IDCs . 21, 26 This close relationship between LCs and IDCs may be the key to this viral interference.
In studies on the modulation of LC function by ultraviolet light, specifically UVB (280-320 nm), suppression of contact hypersensitivity reactions was found following UVB irradiation between 3 and 15 days after irradiation but not at day 1, 40 although others 28 found that UVB suppressed human major histocompatability antigen (HLA-DR) expression on LCs for as long as 24 days in irradiated skin. With glucocorticoids, all LC markers decreased, 1,23 and HLA-DR expression was found to be only 65% normal by 16 days. 28 In ASF, S-100 antigen expression on IDCs is suppressed during a similar 3-14-day period or longer and correlates with the period of interference of ASFV with FMDV infection. These long recovery times for dendritic cell function may relate to the slow turnover rate of LCs 3 and IDCs. 26 The possibility that ASFV infects LCs has been investigated by the authors. Porcine LCs were found to be highly susceptible to infection in vitro. 14, 15 This is a compelling argument for there being a shared target cell for ASFV and FMDV, probably the LC. There is no interference of ASFV infection by prior FMDV infection, as demonstrated by the death of all FMD contact pigs with lesions of acute ASF. Perhaps this is because the essential cell for FMDV infection is the epidermal LCs, and other cells of the mononuclear phagocytic system are not affected and remain susceptible to ASFV infection. Interference with FMDV was incomplete in group DR-2c. Five of 14 pigs had slight or no FMD tongue lesions and no foot or snout lesions. Of these 5 pigs, 3 did not seroconvert to FMDV until after 9 DPI.
Seven of 14 pigs in group DR-2c developed severe clinical FMD similar to that of the FMD group and should have had similar VN titers to FMDV. However, these 7 pins had VN titers to FMDV at 18 DPI that were significantly lower than those of the FMD group at 15 DPI (t-test, P < 0.01) and lower when comparing sera of both these groups taken 1 week earlier at 9 and 11 DPI (t-test, P < 0.01). This impairment of the immune response to FMDV cannot be due to lack of antigenic stimulation because these 7 pigs had FMD lesions that were equally severe and disseminated as the ones of the FMD group. These results indicate that the immune response to FMDV was indeed impaired by ASFV in this group.
In conclusion, virulent ASFV infection interfered with FMDV infection when FMDV was inoculated 3 days after ASFV was inoculated (during ASF viremia). There were no lesions of FMD, few pigs seroconverted to FMDV, and rarely was there detectable antibody produced to ASFV. In contrast, moderately virulent ASFV infection in >40-kg pigs interfered with expression of clinical FMD in a few pigs, but most pigs developed typical FMD lesions and seroconverted to FMDV but had significantly lower titers than did FMDinfected controls. These lower antibody titers may have been due to a partial abrogation of the antigen presenting function of IDCs as a result of ASFV infection. 1.
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Lab-Tek chamber slides, Nunc, Naperville, IL. Vector Lab, Burlingame, CA. ?? Fisher Scientific, Fair Lawn, NJ.
